Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur significant order book increase in a growing market is a great sign of confidence.
Read our latest reportOn Saturday June 10th Urenco Netherlands will open its doors for visitors. Between 11:00 and 16:00 everybody is welcome to enjoy a tour over the site, listen to a presentation on Stable Isotopes and learn more about our Netzero ambitions. The entrance is free of charge. If you want to participate in a tour through our enrichment plant you must register a ticket via bit.ly/opendagurenco (minimum age 14).
The partnership came under the Medical Radionuclide Innovation Programme (MRIP), a £6 million research and development initiative funded by the UK Government.
Read more Urenco Isotopes celebrates successful research and development partnership with King’s College LondonThe partnership came under the Medical Radionuclide Innovation Programme (MRIP), a £6 million research and development initiative funded by the UK Government.
Read more Urenco Isotopes celebrates successful research and development partnership with King’s College LondonWe have teamed up with the Dutch university Tu Delft to develop new generations of nuclear scientists.
Read more Urenco partners with leading nuclear university to invest in talentWe have teamed up with the Dutch university Tu Delft to develop new generations of nuclear scientists.
Read more Urenco partners with leading nuclear university to invest in talentAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries